The Best Diabetes Medicine in the World Doesn't Help If You Can't Get It
Reflections on access and equity from the 2026 American Diabetes Association Scientific Sessions
By Dr. Genevieve, DNP | Vieve Health & Wellness
I just returned from the American Diabetes Association Scientific Sessions in New Orleans, and I want to be honest with you about something. The science this year was breathtaking — new medications that melt away weight and steady blood sugar, sensors that read your glucose around the clock, treatments that protect the heart and kidneys. Walking those halls, you could feel the future of diabetes care arriving.
But I kept returning to one uncomfortable question, and so did many of the experts on the main stage: who actually gets to benefit from all of this? Because a breakthrough that never reaches our communities is not really a breakthrough for us. This piece is about that gap — and what we can do about it.
The quiet theme running through the whole meeting
Alongside all the excitement about new drugs, one of the strongest threads at this year's sessions was equity — the recognition that the most powerful advances are not reaching everyone equally. The experts were direct about it: the field is moving faster than ever, and the very real risk is that the same communities who carry the heaviest burden of diabetes are the last to receive its newest cures.
This is not a new story to those of us in African and diaspora communities. Diabetes hits us hard, often earlier, often with more complications. And the research is clear that social factors — access to nutritious food, safe places to move, affordable care, insurance, time off work — shape diabetes outcomes as much as biology does. The newest 2026 care standards now formally urge clinicians to weigh these social realities and a patient's financial situation when making treatment decisions, not just the lab numbers.
The medication gap is real — and measurable
Take the GLP-1 medications — the Ozempic and Wegovy family that dominated this year's headlines. They work remarkably well. But who is getting them? Research has shown that Black, Hispanic, and other minority patients are consistently less likely to be prescribed these newer diabetes medications than White patients, even when they would benefit just as much. The barriers are not about willingness — they are about cost, insurance coverage, where you live, whether your clinic offers them, and sometimes simple bias in who gets offered what.
Cost alone is staggering. In the United States, a month of one of these medications can run many hundreds of dollars without strong insurance — the same drug that costs a fraction of that in other countries. When a treatment is priced like a luxury, it quietly becomes one, available to those with means and out of reach for those with the greatest need.
Where the good news lives
It is not all discouraging. Several developments from this year's meeting point toward narrowing the gap, not widening it:
- Glucose monitors are reaching more people. New evidence supports continuous glucose monitors for people with type 2 diabetes who are not on insulin — a much larger group, many of whom were previously left out — which strengthens the case for insurers to cover them more broadly.
- Telehealth and remote care are expanding. Phone and video visits, remote monitoring, and app-based programs can reach people who cannot easily get to a clinic — because of distance, work, or transportation.
- Diabetes education is getting its due. There is growing recognition that good education — teaching people how to manage their own condition — is one of the most powerful and underused tools we have. And education travels further and costs less than any single drug.
- Clinicians are being urged to advocate. The conversation now openly includes helping patients navigate prior authorizations, appeals, and financial assistance — the paperwork that too often stands between a person and their medication.
What this means for you and your family
You are not powerless in this. Knowing how the system works is itself a form of access. A few things worth holding onto:
- Ask about every option. If a medication feels out of reach because of cost, ask your provider directly about manufacturer assistance programs, generic or alternative options, and which treatments your insurance actually covers. The answer is often more than you expect.
- Don't underestimate the basics. The newest drug is wonderful, but food, movement, sleep, and stress management remain the foundation — and they belong to you regardless of your insurance. Culturally familiar, affordable foods are powerful medicine in their own right.
- Use education as your equalizer. The more you understand your own condition, the better you can advocate for yourself, ask the right questions, and make the most of whatever care you can access.
- Bring someone with you. Navigating care is easier with support — a family member, a friend, or a health educator who can help you ask questions and remember the answers.
Why this is personal for me
I went into nursing and built Vieve Health & Wellness around a simple conviction: that good health education, delivered in a way that respects who we are and where we come from, is one of the most powerful tools for closing these gaps. The science showcased in New Orleans is extraordinary. My work — and my hope — is to make sure our communities are not the last to benefit from it, but among the first to understand it, ask for it, and use it well.
The bottom line
The 2026 Scientific Sessions made one thing clear: the tools to manage and even reverse the course of diabetes are better than they have ever been. The challenge of our generation is not only inventing them — it is making sure they reach everyone. That work happens in clinics and in policy, but it also happens at kitchen tables, in churches, in WhatsApp groups, and in honest conversations like this one.
The breakthrough only counts when it reaches you. Let's make sure it does.
This article is for general health education and is not a substitute for personalized medical advice. Talk with your own healthcare provider about the treatment and support options available to you.
